Form 4: MapLight Therapeutics CEO Sells Shares
Insider Transaction (Form 4)
Christopher A. Kroeger, Chief Executive Officer and a Director of MapLight Therapeutics, Inc., sold 73,691 shares of common stock on October 15, 2026 for $8.08 per share.
Summary
- Open-market sale: disposed of 73,691 Voting Common Stock at $8.08 ($595,423) on October 15, 2026; holds 1,195,909 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative signal: an insider sold $595,423 of stock on the open market.
Insider Transactions
Christopher A. Kroeger — Director, Officer (Chief Executive Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-10-15 | Open-market sale | Voting Common Stock | 73,691 | $8 | $595.4K | 1,195,909 |
Key Dates
| Date | Description |
|---|---|
| 2026-10-15 | Open-market sale (73,691 shares) |
Keywords
insider transaction, Form 4, MPLT, MapLight Therapeutics, Inc., bearish, Christopher A. Kroeger
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.